<- Back to digest

Journal of Pediatric Orthopaedics - 2026-07-24 - Journal Article

STAC3D Against the Odds: Characterizing the Musculoskeletal Phenotype of STAC3 Gene Disorder.

Adams NC, Choudhari M, Visco ZR, Vergun A, Stone J, Sanders JO, Mitchell SL

retrospective cohortLOE IVn = 26 total, n=23 with musculoskeletal dataMedian age at data collection 4 years (range 25 days to 55 years); not a defined prospective follow-up interval.

Topics

pediatrics
PMID: 42490135DOI: 10.1097/BPO.0000000000003424View on PubMed ->

Key Takeaway

In the largest North American cohort of STAC3 Disorder patients (n=23 with musculoskeletal data), scoliosis occurred in 83%, congenital foot deformity in 61%, and 57% required at least one orthopaedic procedure.

Summary Depth

Choose how much analysis to show on this article page.

Summary

This single-institution retrospective cohort characterized the musculoskeletal phenotype of STAC3 Disorder across 26 patients diagnosed 2014–2025. Scoliosis was present in 83%, hyperkyphosis in 48%, joint contractures in 61%, and congenital foot deformity in 61% (13 clubfoot, 1 bilateral vertical talus); median height and weight percentiles were both 1%. This represents the first systematic assessment of musculoskeletal condition rates in STAC3D and the second largest global cohort reported.

Key Limitation

The cohort of 23 patients with musculoskeletal data is too small to define reliable prevalence estimates or identify predictors of orthopaedic intervention need, and single-institution referral bias likely overrepresents severe phenotypes.

Original Abstract

INTRODUCTION

STAC3 Disorder (STAC3D) is a rare genetic condition characterized by musculoskeletal abnormalities, myopathic facies, palatal anomalies, micrognathia, short stature, and an increased susceptibility to malignant hyperthermia. It was initially described in the Lumbee Native Americans of North Carolina, though it is now found globally. This study aims to characterize the musculoskeletal phenotype of STAC3D to aid in its diagnosis and clinical management.

METHODS

A retrospective cohort study of STAC3D patients from 2014 to 2025 at a single institution was conducted. Patients diagnosed with STAC3D were included. Data collected included demographics, genetic testing, musculoskeletal conditions, and their management. Descriptive and comparative statistics were utilized, with rates reported as percentages and variables expressed as median and means with standard deviation.

RESULTS

A total of 26 patients met the selection criteria and were included; 23 patients had musculoskeletal data available for analysis. The median age at diagnosis and time of data collection was 22 days and 4 years (25 d to 55 y), respectively (n=26). The median height and weight percentiles are 1%. In all, 83% (n=19/23) of patients had scoliosis, 48% (n=11/23) had hyperkyphosis, 61% (n=14/23) had joint contractures (8 upper extremity, 3 lower extremity, 3 unspecified), and 61% (n=14/23) had a congenital foot deformity (13 clubfoot deformities, 1 bilateral vertical talus). In all, 57% (n=13/23) of all STAC3D patients required at least one orthopaedic procedure, 78% (n=18/23) underwent at least one non-orthopaedic surgery, and 87% (n=20/23) had at least one general anesthesia event.

CONCLUSION

STAC3D is associated with many musculoskeletal problems, including spinal and congenital foot deformities, joint contractures, and other less frequent pathologies. This study is the first to assess the rates of all musculoskeletal conditions in STAC3D patients. Our cohort represents the largest North American cohort and the second largest global cohort of STAC3D patients in the current literature. The results of our study aim to facilitate early diagnosis and expectation management of STAC3D.

LEVEL OF EVIDENCE IV

This is a retrospective cohort study aimed at describing the musculoskeletal conditions associated with STAC3D.